What Happened?
Ridgefield, CT-based Boehringer Ingelheim Appointed Mary Sullivan as Executive Director, Director, Regulatory Affairs, Advertising and Promotion Compliance
About the Company
For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees.
About the Person
Mary Sullivan is Executive Director, Director, Regulatory Affairs, Advertising and Promotion Compliance at Boehringer Ingelheim. Previously, Mary held various senior legal leadership roles in the industry.
Info Source
News
Short Profile